Increased susceptibility to airway responses in CD40-deficient mice

Clinical and Experimental Immunology

Volumn 133, Issue 1, 2003, Pages 22-29

  Takahashi, H ^a   Ebihara, S ^a   Kanda, A ^a   Kamanaka, M ^a,b   Sato, T ^c   Habu, S ^c   Kikutani, H ^b   Sasaki, Hidetada ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

Airway hyperreactivity; CD40; Eosinophil; Th1 Th2 ratio

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 12; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BACKCROSSING; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; EOSINOPHILIA; HELPER CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; LUNG LAVAGE; LYMPH NODE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD40; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTOR AGENTS; CD40 LIGAND; DISEASE SUSCEPTIBILITY; EOSINOPHILS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LEUKOCYTE COUNT; LUNG; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL;

EID: 0038723643     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02182.x     Document Type: Article

References (28)

1. + cells in human allergic diseases. J Allergy Clin Immunol 1997; 100:1-6.
2. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin-5 deficiency abolishes eosinophilia airways hyperreactivity and lung damage in a mouse asthma model. J Exp Med 1996; 183:195-201.
3. Brusselle G, Kips J, Koos G, Bluethmann H, Pauwels R. Allergen-induced airway inflammation and bronchial responsiveness in wild type and interleukin-4 deficient mice. Am J Respir Cell Mol Biol 1995; 12:254-9.
4. Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, Durham SR, Kay AB. The immunopathology of extrinsic (atopic) and instrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999; 20:528-34.
5. Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12:881-922.
6. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16:111-35.
7. Torres RM, Clark EA. Differential increase of an alternatively polyadenylated mRNA species of murine CD40 upon B lymphocyte activation. J Immunol 1992; 148:620-6.
8. Jabara HH, Fu SM, Geha RS, Vercelli D. CD40 and IgE synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 1990; 172:1861-4.
9. + T cell colnes and IL-4 induce IgG4 and IgE switching in purified human B cell via different signaling pathways. J Immunol 1991; 147:8-13.
10. Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H. Protective role of CD40 in Leishimania major infection at two distinct phases of cell-mediated immunity. Immunity 1996; 4:275-81.
11. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukocyte Biol 2000; 67:2-17.
12. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 1997; 99:1329-39.
13. Lei XF, Ohkawara Y, Stampfli MR, Mastruzzo C, Marr RA, Snider D, Xing Z, Jordana M. Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice. J Clin Invest 1998; 101:1342-53.
14. Mehlhop PD, van de Rijn M, Brewer JP, Kisselgof AB, Geha RS, Oettgen HC, Martin TR. CD40L, but not CD40, is required for allergen-induced bronchial hyperresponsiveness in mice. Am J Respiratory Cell Mol Biol 2000; 23:646-51.
15. Sato T, Sasahara T, Nakamura Y, Osaki T et al. Naïve T cells can mediate delayed-type hypersensitivity response in T cell receptor transgenic mice. Eur J Immunol 1994; 24:1512-6.
16. Kawabe T, Naka T, Yoshida K et al. The immune responses in CD40-dficient mice impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1:167-78.
17. Ohno I, Lea RG, Flanders KC et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 1992; 89:1662-8.
18. Busse WW, Lemanske RF Jr. Asthma. New England J Med 2001; 344:350-62.
19. William TL, Calkins JC, Street NE. Memory T cell development in the absence of specific antigen priming. J Immunol 1996; 157:5300-7.
20. +T helper cell phenotype development in a T cell receptor-alpha beta-tansgenic model. J Exp Med 1995; 182:1579-84.
21. Herrick CA, MacLeod H, Glusac E, Tigelaar RE, Bottomly K. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest 2000; 105:765-75.
22. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996; 4:283-9.
23. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995; 182:1527-36.
24. Tournoy KG, Kips JC, Pauwels RA. Counterbalancing of TH2-driven allergic airway inflammation by IL-12 does not require IL-10. J Allergy Clin Immunol 2001; 107:483-91.
25. Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. Med Inflammation 2001; 10:51-9.
26. Kips JC, Brusselle GJ, Joos GF, Peleman RA, Tavernier JH, Devos RR, Pauwels RA. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respiratory Crit Care Med 1996; 153:535-9.
27. Zhao LL, Linden A, Sjostrand M, Cui ZH, Lotvall J, Jordana M. IL-12 regulates bone marrow eosinophilia and airway eotaxin levels induced by airway allergen exposure. Allergy 2000; 55:749-56.
28. Rackeman FM. A working classification of asthma. Am J Med 1947; 3:601-6.